| Prev Close: | 2.01 |
|---|---|
| Open: | N/A |
| Bid: | 1.98 x 500 |
| Ask: | 2.01 x 2000 |
| 1y Target Est: | 1.00 |
| Beta: | 1.97 |
| Next Earnings Date: | 12-Aug-13 |
| Day's Range: | 1.98 - 1.98 |
|---|---|
| 52wk Range: | 1.23 - 3.73 |
| Volume: | 2,043 |
| Avg Vol (3m): | 48,727 |
| Market Cap: | 53.61M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.61 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ENTREMED INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of SecuriEDGAR Online(Mon Jun 3)
- 4 Health Care Stocks Under $10 to Watchat TheStreet(Fri May 31)
- ENTREMED INC FinancialsEDGAR Online Financials(Tue May 21)
- EntreMed Reports First Quarter 2013 Financial ResultsPR Newswire(Wed May 15)
- ENTREMED INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Wed May 15)
- Patent Issued In China For EntreMed's Lead Drug Candidate ENMD-2076PR Newswire(Mon May 6)
- EntreMed announced issurance of U.S. patent for 2ME2theflyonthewall.com(Fri May 3)
- Patent Issued In U.S. For EntreMed's 2ME2 In Rheumatoid DiseasesPR Newswire(Fri May 3)
- ENTREMED INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online(Tue Apr 9)
- EntreMed Announces Changes to Board of Directors and CEO AppointmentPR Newswire(Fri Apr 5)
- EntreMed Reports Fourth Quarter And Year-End 2012 Financial Results And Business Outlook For 2013PR Newswire(Thu Mar 21)
- ENTREMED INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Thu Mar 21)
- China Biotech In Review: WuXi PharmaTech Reports Another Year Of Steadily Increasing Growthat Seeking Alpha(Sun Mar 10)
- ENTREMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online(Wed Mar 6)
- Sabby Management reports 6.17% passive stake in EntreMedtheflyonthewall.com(Wed Mar 6)
Press Releases
- EntreMed Reports First Quarter 2013 Financial ResultsPR Newswire(Wed May 15)
- Patent Issued In China For EntreMed's Lead Drug Candidate ENMD-2076PR Newswire(Mon May 6)
- Patent Issued In U.S. For EntreMed's 2ME2 In Rheumatoid DiseasesPR Newswire(Fri May 3)
Must Read
- Exclusive: Parmalat should cut LAG price by $151 million, report to court saysReuters(1969-12-31T18:59:59GMT-05:00)
- Bank of Canada says business confidence crucial, urges patienceReuters(1969-12-31T18:59:59GMT-05:00)
- Vimpelcom unit drops bid to buy Canada's Wind MobileReuters(1969-12-31T18:59:59GMT-05:00)
- Cisco to invest in Israeli venture capital fundsReuters(1969-12-31T18:59:59GMT-05:00)
- Loblaw tests out new smaller discount grocery store format in CalgaryThe Canadian Press(1969-12-31T18:59:59GMT-05:00)